[go: up one dir, main page]

NO833961L - Faste doseringsformer med ikke-ensartet fordeling av aktivt medikament for forsinket frigivelse av dette - Google Patents

Faste doseringsformer med ikke-ensartet fordeling av aktivt medikament for forsinket frigivelse av dette

Info

Publication number
NO833961L
NO833961L NO833961A NO833961A NO833961L NO 833961 L NO833961 L NO 833961L NO 833961 A NO833961 A NO 833961A NO 833961 A NO833961 A NO 833961A NO 833961 L NO833961 L NO 833961L
Authority
NO
Norway
Prior art keywords
dosage forms
delayed release
active medicine
fixed dosage
similar distribution
Prior art date
Application number
NO833961A
Other languages
English (en)
Other versions
NO163356C (no
NO163356B (no
Inventor
Michael A Zoglio
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of NO833961L publication Critical patent/NO833961L/no
Publication of NO163356B publication Critical patent/NO163356B/no
Publication of NO163356C publication Critical patent/NO163356C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO833961A 1982-11-01 1983-10-31 Fremgangsmaate for fremstilling av en farmasoeytisk tablettsom gir hovedsakelig nullte ordens frigivelse av medikament. NO163356C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US43810082A 1982-11-01 1982-11-01
US53612883A 1983-09-27 1983-09-27

Publications (3)

Publication Number Publication Date
NO833961L true NO833961L (no) 1984-05-02
NO163356B NO163356B (no) 1990-02-05
NO163356C NO163356C (no) 1990-05-16

Family

ID=27031546

Family Applications (1)

Application Number Title Priority Date Filing Date
NO833961A NO163356C (no) 1982-11-01 1983-10-31 Fremgangsmaate for fremstilling av en farmasoeytisk tablettsom gir hovedsakelig nullte ordens frigivelse av medikament.

Country Status (13)

Country Link
EP (1) EP0111144B1 (no)
KR (1) KR900007311B1 (no)
AU (1) AU554377B2 (no)
CA (1) CA1220137A (no)
DE (1) DE3368011D1 (no)
DK (1) DK499183A (no)
ES (1) ES8607008A1 (no)
GR (1) GR78740B (no)
IE (1) IE56182B1 (no)
IL (1) IL70071A (no)
NO (1) NO163356C (no)
NZ (1) NZ206094A (no)
PH (1) PH20332A (no)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE33994E (en) * 1983-08-16 1992-07-14 Burroughs Wellcome Co. Pharmaceutical delivery system
US4624848A (en) * 1984-05-10 1986-11-25 Ciba-Geigy Corporation Active agent containing hydrogel devices wherein the active agent concentration profile contains a sigmoidal concentration gradient for improved constant release, their manufacture and use
US4749576A (en) * 1984-05-10 1988-06-07 Ciba-Geigy Corporation Active agent containing hydrogel devices wherein the active agent concentration profile contains a sigmoidal concentration gradient for improved constant release, their manufacture and use
CA1239034A (en) * 1984-08-17 1988-07-12 Kelly L. Smith Delivery system
EP0297650A1 (en) * 1987-06-26 1989-01-04 Duphar International Research B.V Compositions with controlled zero-order delivery rate and method of preparing these compositions
US5219575A (en) * 1987-06-26 1993-06-15 Duphar International Research B.V. Compositions with controlled zero-order delivery rate and method of preparing these compositions
CN1053570C (zh) * 1987-10-07 2000-06-21 默尔多药物公司 哌啶子基链烷醇的药用组合物-减充血剂复方的制备方法
US4996061A (en) * 1987-10-07 1991-02-26 Merrell Dow Pharmaceuticals Inc. Pharmaceutical composition for piperidinoalkanol-decongestant combination
US4999226A (en) * 1988-06-01 1991-03-12 Merrell Dow Pharmaceuticals Inc. Pharmaceutical compositions for piperidinoalkanol-ibuprofen combination
US5085865A (en) * 1989-04-12 1992-02-04 Warner-Lambert Company Sustained release pharmaceutical preparations containing an analgesic and a decongestant
US5198227A (en) * 1990-01-22 1993-03-30 Mcneil-Ppc, Inc. Dual subcoated simulated capsule medicament
EP0707475B1 (en) * 1993-06-14 1997-09-17 Janssen Pharmaceutica N.V. Extended release, film-coated tablet of astemizole and pseudoephedrine
US5484607A (en) * 1993-10-13 1996-01-16 Horacek; H. Joseph Extended release clonidine formulation
US5451409A (en) * 1993-11-22 1995-09-19 Rencher; William F. Sustained release matrix system using hydroxyethyl cellulose and hydroxypropyl cellulose polymer blends
US5393765A (en) * 1993-12-13 1995-02-28 Hoffmann-La Roche Inc. Pharmaceutical compositions with constant erosion volume for zero order controlled release
DE19608423A1 (de) * 1996-03-05 1997-09-11 Merck Patent Gmbh Implantate mit phasenweiser Arzneistoffabgabe
US5948437A (en) * 1996-05-23 1999-09-07 Zeneca Limited Pharmaceutical compositions using thiazepine
EP0811374A1 (en) 1996-05-29 1997-12-10 Pfizer Inc. Combination dosage form comprising cetirizine and pseudoephedrine
US6197340B1 (en) 1998-05-28 2001-03-06 Medical Research Institute Controlled release lipoic acid
DE10031043A1 (de) 2000-06-26 2002-02-14 Bayer Ag Retardzubereitungen von Chinolonantibiotika und Verfahren zu ihrer Herstellung
KR100402053B1 (ko) * 2000-09-28 2003-10-17 한국화학연구원 항생제의 서방성 임플란트 제제
CA2464653C (en) * 2001-10-29 2011-10-18 Therics, Inc. System for manufacturing controlled release dosage forms, such as a zero-order release profile dosage form manufactured by three-dimensional printing
SA07280459B1 (ar) 2006-08-25 2011-07-20 بيورديو فارما إل. بي. أشكال جرعة صيدلانية للتناول عن طريق الفم مقاومة للعبث تشتمل على مسكن شبه أفيوني
AU2008261957A1 (en) 2007-06-08 2008-12-18 Addrenex Pharmaceuticals, Inc. Extended release formulation and method of treating adrenergic dysregulation
SG191288A1 (en) 2010-12-22 2013-07-31 Purdue Pharma Lp Encased tamper resistant controlled release dosage forms
PH12013501345A1 (en) 2010-12-23 2022-10-24 Purdue Pharma Lp Tamper resistant solid oral dosage forms
US10751287B2 (en) 2013-03-15 2020-08-25 Purdue Pharma L.P. Tamper resistant pharmaceutical formulations
US10702548B2 (en) 2015-03-04 2020-07-07 Joelle Michele Forbes Compositions and methods for treating drug addiction

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1139869A (en) * 1966-01-06 1969-01-15 Moore Medicinal Products Ltd Improvements in or relating to tablets
US3965255A (en) * 1974-05-01 1976-06-22 E. E. Eljim Ecology Ltd. Controlled drug releasing preparations
SE418247B (sv) * 1975-11-17 1981-05-18 Haessle Ab Sett att framstella kroppar med reglerad frigoring av en aktiv komponent
US4122157A (en) * 1977-03-04 1978-10-24 Richardson-Merrell Inc. Nitrofurantoin sustained release tablet
GB2042888B (en) * 1979-03-05 1983-09-28 Teijin Ltd Preparation for administration to the mucosa of the oral or nasal cavity
US4291015A (en) * 1979-08-14 1981-09-22 Key Pharmaceuticals, Inc. Polymeric diffusion matrix containing a vasodilator

Also Published As

Publication number Publication date
IE832543L (en) 1984-05-01
AU554377B2 (en) 1986-08-21
DK499183D0 (da) 1983-10-31
IE56182B1 (en) 1991-05-08
CA1220137A (en) 1987-04-07
NO163356C (no) 1990-05-16
ES8607008A1 (es) 1986-06-16
DE3368011D1 (en) 1987-01-15
DK499183A (da) 1984-05-02
EP0111144B1 (en) 1986-12-03
KR900007311B1 (ko) 1990-10-08
IL70071A (en) 1987-12-31
EP0111144A1 (en) 1984-06-20
AU2080383A (en) 1984-05-10
NZ206094A (en) 1986-10-08
KR840006765A (ko) 1984-12-03
IL70071A0 (en) 1984-01-31
PH20332A (en) 1986-12-02
NO163356B (no) 1990-02-05
ES526901A0 (es) 1986-06-16
GR78740B (no) 1984-10-02

Similar Documents

Publication Publication Date Title
NO833961L (no) Faste doseringsformer med ikke-ensartet fordeling av aktivt medikament for forsinket frigivelse av dette
IL57796A0 (en) Pharmaceutical compositions having retarded release of the active substance
NO173238C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 7-beta-(karboksyalkenoylamino)-3-cefem-4-karboksylsyre-forbindelser
NO171209C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive morfinanestere
IT8267184A0 (it) Bendaggio per la somministrazione di medicamenti
FI831998L (fi) Foerfarande foer framstaellning av farmaceutiskt aktiva pyrazinonderivat
ES497279A0 (es) Procedimiento de inyeccion de cantidades dosificadas de ma- terias pulverulentas e instalacion correspondiente
NO163693C (no) Fremgangsmaate for fremstilling av terapeutisk aktive forbindelser av platina.
DK537685D0 (da) Fremgangsmaade til fremstilling af isosilybinfrit silibinin samt laegemiddel med indhold deraf
NO833279L (no) Farmasoeytiske preparater for behandling av uoensket sammenvoksing
NO162619C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive l-aminosyre-derivater
SE7604317L (sv) Fast farmaceutisk doseringsform med fordrojd frigoring och sett att framstella desamma
NO830238L (no) Fremgangsmaate for fremstilling av farmakologisk aktive urinstoffer og tiourinstoffer
NO834729L (no) Fremgangsmaate for fremstilling av farmakologisk aktive tio-cefalosporiner
NO151319C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive beta-mono-fluormetyl-beta-alanin- og beta-difluormetyl-beta-alanin-forbindelser
HUT37036A (en) Process for preparing pharmaceutical compositions with retarded release of the active substance
NO833527L (no) Fremgangsmaate for fremstilling av terapeutisk aktive fenyl-cyklobutylderivater
NO820112L (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyridoindol-derivater
NO164899C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazolylindolforbindelser.
NO830900L (no) Fremgangsmaate for fremstilling av terapeutisk aktive tricykliske derivater.
NO831995L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive n-(2-metoksyetyl)-noroksymorfon
NO834437L (no) Fremgangsmaate for fremstilling av terapeutisk aktive spiro-3-hetero-azolon-derivater
NO832430L (no) Fremgangsmaate for fremstilling av terapeutisk aktive fenyleddiksyre-derivater
ZA838033B (en) Sustained release solid dosage forms having non-uniform distribution of active ingredient
NO164773C (no) Analogifremgangsmaate for fremstilling av forbindelser medfarmasoeytisk virkning.